Table 3 Univariate and multivariate regression model on patient survival
Univariate | Multivariate | |||
|---|---|---|---|---|
HR (95% CI) | P | HR (95% CI) | P | |
Primary therapeutic intervention | ||||
cTACE vs DC-Bead | 0.985 (0.623–1.559) | 0.949 | — | — |
Clinical characteristics | ||||
Age (year) | 1.024 (0.992–1.057) | 0.144 | — | — |
Male vs female | 0.708 (0.419–1.194) | 0.195 | — | — |
Viral cirrhosis vs non-viral | 1.535 (0.881–2.673) | 0.130 | — | — |
Alcohol consumption | 0.453 (0.225–0.911) | 0.026 | 0.553 (0.278–1.102) | 0.092 |
Child-Pugh class B vs A class | 1.889 (1.053–3.387) | 0.033 | 1.109 (0.560–2.196) | 0.766 |
ECOG 1 vs 0 | 1.635 (1.003–2.665) | 0.049 | 1.904 (1.148–3.155) | 0.013 |
Serum albumin (per g l−1) | 0.936 (0.899–0.974) | 0.001 | 0.955 (0.915–0.997) | 0.036 |
MELD score (per unit) | 1.062 (0.961–1.173) | 0.239 | — | — |
Tumour burden | ||||
Multiple tumours vs single tumours | 2.455 (1.488–4.049) | 0.001 | 2.860 (1.692–4.833) | 0.001 |
BCLC Stage C vs B vs Stage A | 1.342 (1.020–1.766) | 0.035 | 1.078 (0.599–1.939) | 0.803 |
Bilobar involvement vs monolobar | 1.360 (0.732–2.527) | 0.330 | — | — |
Largest tumour diameter (per cm) | 1.002 (0.989–1.014) | 0.805 | — | — |
Segmental injection | 1.075 (0.656–1.761) | 0.775 | — | — |
